O'Day Daniel Patrickinsider trades
In SEC Form 4 filings, O'Day Daniel Patrick is listed as Chairman & CEO of Gilead Sciences, Inc. (GILD). In the last 90 days, O'Day Daniel Patrick sold $4.45M of Gilead Sciences, Inc. (GILD) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| GILDGilead Sciences, Inc. | Chairman & CEO | 8 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Oct 1 | Oct 2 | S | 12,000 | $147.72 | Sale −$1,772,628 | 569,683 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Oct 1 | Oct 2 | S | 3,000 | $148.63 | Sale −$445,880 | 566,683 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M | 8,780 | not reported | not reported | 585,913 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | F | 4,230 | $144.81 | $612,546 | 581,683 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M · derivative | 8,780 | not reported | not reported | 83,300 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 1 | Sep 2 | S | 1,600 | $147.51 | Sale −$236,014 | 590,533 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Sep 1 | Sep 2 | S | 7,992 | $148.36 | Sale −$1,185,722 | 582,541 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Sep 1 | Sep 2 | S | 5,408 | $149.38 | Sale −$807,856 | 577,133 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.